Sergliflozin-A
Sergliflozin-A is a compound used to inhibit type 2 diabetes. It can inhibit glucose transporters in the kidney, competitively inhibit hSGLT1 and hSGLT2, and mutations at different sites have different effects on its inhibitory effect.
Product Specifications
CAS Number
360775-96-8
UNSPSC
12352005
Target
SGLT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/sergliflozin-a.html
Smiles
COC(C=C1)=CC=C1CC(C=CC=C2)=C2O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO
Molecular Formula
C20H24O7
Molecular Weight
376.40
References & Citations
[1]Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and …
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SGLT1; SGLT2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882228-100 1x 100 µL
MAPK14 (CPTC-MAPK14-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY423218 100 µg
SLC6A17 (NM_001010898) Human Over-expression Lysate
Sign In for Pricing
View Details